Know Cancer

or
forgot password


Phase 2
N/A
80 Years
Not Enrolling
Both
Peritoneal Carcinomatosis, Gastric Cancer

Thank you

Trial Information


Inclusion Criteria:



- Histologically confirmed diagnosis of primary gastric cancer + histologically and/or
radiologically confirmed peritoneal carcinomatosis diagnosis

- Adequate renal-, hematopoietic- and liver functions

- WHO performance status (WHO) of < 2.

Exclusion Criteria:

- Distant metastases

- Surgically not resectable lymph-node metastasis

- Contraindication to chemotherapy treatment

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Overall survival

Outcome Time Frame:

Jan 2005 until Mars 2009

Safety Issue:

No

Authority:

Sweden: Socialstyrelsen

Study ID:

2007/073

NCT ID:

NCT01379482

Start Date:

January 2005

Completion Date:

March 2009

Related Keywords:

  • Peritoneal Carcinomatosis
  • Gastric Cancer
  • Peritoneal carcinomatosis from gastric cancer
  • Stomach Neoplasms
  • Carcinoma

Name

Location